Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hyman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biomedical Instrumentation & Technology|January 27, 2015
On recallsWilliam Hyman
Biomedical Instrumentation & Technology|July 22, 2015
Are Safety Standards Ever Proven to Enhance Safety?William Hyman
Biomedical Instrumentation & Technology|January 8, 2005
What does productivity mean?William Hyman
BMC Musculoskeletal Disorders|February 28, 2002
Modeling of failure mode in knee ligaments depending on the strain rateMija Lee, William Hyman
Southern Medical Journal|September 7, 2010
Skin cancer: knowledge, behaviors, and attitudes of college studentsKimberly Spradlin, Martha Bass, William Hyman, et al.
BMJ Case Reports|May 12, 2025
Glioblastoma with metastasis to the bone marrowZhixin Jiang, Chunyu Cai, Nawal Shaikh, et al.
Biomedical Instrumentation & Technology|December 19, 2007
Overcoming barriers to success: collecting medical device incident dataYadin David, William Hyman, Vicky D Woodruff, et al.
Schizophrenia Bulletin|April 10, 2009
Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?Dennis K Kinney, Pamela Teixeira, Diane Hsu, et al.
Clinical Lymphoma|January 13, 2004
Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimenRobert Drapkin, Nicholas J Di Bella, David C Faragher, et al.
Clinical Colorectal Cancer|November 28, 2008
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancerThomas Cartwright, Paul Kuefler, Allen Cohn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomedical Instrumentation & Technology|January 27, 2015
On recallsWilliam Hyman
Biomedical Instrumentation & Technology|July 22, 2015
Are Safety Standards Ever Proven to Enhance Safety?William Hyman
Biomedical Instrumentation & Technology|January 8, 2005
What does productivity mean?William Hyman
BMC Musculoskeletal Disorders|February 28, 2002
Modeling of failure mode in knee ligaments depending on the strain rateMija Lee, William Hyman
Southern Medical Journal|September 7, 2010
Skin cancer: knowledge, behaviors, and attitudes of college studentsKimberly Spradlin, Martha Bass, William Hyman, et al.
BMJ Case Reports|May 12, 2025
Glioblastoma with metastasis to the bone marrowZhixin Jiang, Chunyu Cai, Nawal Shaikh, et al.
Biomedical Instrumentation & Technology|December 19, 2007
Overcoming barriers to success: collecting medical device incident dataYadin David, William Hyman, Vicky D Woodruff, et al.
Schizophrenia Bulletin|April 10, 2009
Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?Dennis K Kinney, Pamela Teixeira, Diane Hsu, et al.
Clinical Lymphoma|January 13, 2004
Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimenRobert Drapkin, Nicholas J Di Bella, David C Faragher, et al.
Clinical Colorectal Cancer|November 28, 2008
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancerThomas Cartwright, Paul Kuefler, Allen Cohn, et al.
Pageof 2